Fiona Cresswell is a UK-trained Physician with expertise in HIV Medicine, Sexual Health and Tropical Medicine. She practices medicine at the University Hospital Sussex in the UK and holds an Academic Clinical Lectureship at Brighton and Sussex Medical School.
The main focus of her research is improving HIV treatment in sub-Saharan Africa and reducing mortality from advanced HIV disease. In 2016, she joined the brain infections research group at the Infectious Diseases Institute, Kampala, Uganda, and began a Wellcome-funded Clinical PhD Fellowship through the London School of Hygiene and Tropical Medicine. She is part of the HARVEST international TB meningitis consortium conducting a multi-country phase III trial investigating high dose rifampicin.
She is also interested in the role that injectable antiretroviral therapy can play in maintaining viral suppression, averting poor HIV outcomes or HIV transmission, and identifying ways to accurately target long-acting ART in Africa. She is Chief Investigator of a phase III clinical trial called IMPALA – Improving HIV outcomes in Africa with Long-acting Antiretroviral therapy - with MRC/UVRI-LSHTM Uganda Research Unit and is site Principal Investigator for CARES - Cabotegravir and Rilpivirine Efficacy and Safety study - at the Infections Diseases Institute, Uganda. She is leading on observational cohort study of real-world use of cabotegravir and rilpivirine (CORAL study) in the UK.
